Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)-Reference-Cited by-同舟云学术

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)

Published:2024-04-17 Issue:2 Volume:168 Page:299-306
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Gately Lucy,Mesía C.,Sepúlveda J. M.,del Barco S.,Pineda E.,Gironés R.,Fuster J.,Dumas M.,Gill S.,Navarro L. M.,Herrero A.,Dowling A.,de las Peñas R.,Vaz M. A.,Alonso M.,Lwin Z.,Harrup R.,Peralta S.,Long A.,Perez-Segura P.,Ahern E.,Garate C. O.,Wong M.,Campbell R.,Cuff K.,Jennens R.,Gallego O.,Underhill C.,Martinez-Garcia M.,Covela M.,Cooper A.,Brown S.,Rosenthal M.,Torres J.,Collins I. M.,Gibbs P.,Balana C.

Funder

Victorian Comprehensive Cancer Centre

Spanish Institute Carlos III

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11060-024-04668-5.pdf

Reference35 articles.

1. Ostrom QT, Patil N, Cioffi G et al (2020) CBTRUS Statistical Report: primary brain and other central nervous system tumours diagnosed in the United States in 2013–2017. Neuro Oncol 22(12 Suppl 2):iv1–iv96

2. Liu Y, Wasilewski A, Mohile NA (2020) Disparities in patient enrollment on glioblastoma clinical trials. CNS Oncol 9(2):CNS59

3. Stupp R, Mason WP, van den Bent MJ, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

4. Stupp R, Hegi ME, Mason WP, van den Bent MJ, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466

5. Malmström A, Grønberg BH, Marosi C et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the nordic randomised, phase 3 trial. Lancet Oncol 13:916–926

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapeutic advances in the management of glioblastoma;Journal of Neuro-Oncology;2024-09-13